Pregnancy Labeling: FDA Should Follow EMEA’s Lead On Classification, Firms Say
Executive Summary
FDA should adopt the European Medicines Agency's categorizations of pregnancy risk information in labeling, industry recommends in comments on the agency's proposed rule